Bioinformatics startup Proscia announced a multi-year distribution agreement with life science company Agilent Technologies, to provide a digital system for diagnosing pathology.
Proscia’s AI-powered platform, Concentriq Dx, provides applications that support pathologists with research and diagnosis of cancer. Agilient plans to integrate Proscia’s platform with its pathology staining products, allowing pathology labs to enhance diagnostic efficiency and accuracy.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.